Literature DB >> 16682954

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.

V Subbarayan1, P Krieg, L C Hsi, J Kim, P Yang, A L Sabichi, N Llansa, G Mendoza, C J Logothetis, R A Newman, S M Lippman, D G Menter.   

Abstract

An inverse relationship exists between the expression of 15-lipoxygenase-2 (15-LOX-2) and peroxisome proliferator-activated receptor gamma (PPARgamma) in normal prostate epithelial cells (PrECs) compared with their expression in prostate carcinoma cells (PC-3). The reason for this difference, however, is unknown. We hypothesized that this inverse expression partly involves the 15-LOX-2 promoter and 15-S-hydroxyeicosatetraenoic acid (15-(S)-HETE), a product of 15-LOX-2 that binds to PPARgamma. We identified an active steroid nuclear receptor half-site present in the 15-LOX-2 promoter fragment F-5 (-618/+177) that can interact with PPARgamma. After forced expression of wild-type PPARgamma, 15-(S)-HETE (1 microM) decreased F-5 reporter activity in PrECs whereas forced expression of 15-LOX-2 resulted in 15-(S)-HETE production which enhanced F-5 activity in PC-3. In contrast, the expression of dominant-negative PPARgamma reversed the transcriptional activation of F-5 by enhancing it 202-fold in PrEC or suppressing it in PC-3; the effect in PC-3 was positively increased 150-fold in the presence of 15-(S)-HETE (1 microM). Peroxisome proliferator-activated receptor gamma interacted with 15-LOX-2 promoter sequences in pulldown experiments using biotinylated 15-LOX-2 (-560/-596 bp) oligonucleotides. In gelshift analyses PPARgamma and orphan receptor RORalpha were shown to interact with the F-5 fragment in PC-3 cells. These data suggest that crosstalk mechanisms exist between the 15-LOX-2 gene and PPARgamma to counterbalance expression and help explain the inverse relationship of these genes in normal versus cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682954     DOI: 10.1038/sj.onc.1209617

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

Review 2.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

Review 3.  Mammalian lipoxygenases and their biological relevance.

Authors:  Hartmut Kuhn; Swathi Banthiya; Klaus van Leyen
Journal:  Biochim Biophys Acta       Date:  2014-10-12

4.  Effect of allergy and inflammation on eicosanoid gene expression in CFTR deficiency.

Authors:  Justin S Bickford; Christian Mueller; Kimberly J Newsom; Sarah J Barilovits; Dawn E Beachy; John D Herlihy; Benjamin Keeler; Terence R Flotte; Harry S Nick
Journal:  J Cyst Fibros       Date:  2012-09-15       Impact factor: 5.482

5.  15-Lipoxygenase eicosanoids are the putative ligands for vanilloid receptors and peroxisome proliferator-activated receptors (PPARs).

Authors:  Ulaganathan Mabalirajan; Anurag Agrawal; Balaram Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-29       Impact factor: 11.205

6.  15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival.

Authors:  Joseph T O'Flaherty; Yungping Hu; Rhonda E Wooten; David A Horita; Michael P Samuel; Michael J Thomas; Haiguo Sun; Iris J Edwards
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Authors:  M V Suraneni; R Schneider-Broussard; J R Moore; T C Davis; C J Maldonado; H Li; R A Newman; D Kusewitt; J Hu; P Yang; D G Tang
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

8.  A Role for the PPARgamma in Cancer Therapy.

Authors:  Moray J Campbell; Carsten Carlberg; H Phillip Koeffler
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

9.  Cytomegalovirus Infection Triggers the Secretion of the PPARγ Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures.

Authors:  Kaoutar Leghmar; Nicolas Cenac; Maude Rolland; Hélène Martin; Benjamin Rauwel; Justine Bertrand-Michel; Pauline Le Faouder; Mélinda Bénard; Charlotte Casper; Christian Davrinche; Thierry Fournier; Stéphane Chavanas
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.